These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Cytosolic pS2 levels in 154 non-small-cell lung carcinomas. Correlation with other clinical and biological parameters]. Ruibal A, Núñez MI, del Río MC, García Díez S, Rodríguez J, Alvarez De Linera JA. Rev Esp Med Nucl; 2002 Apr; 21(2):109-14. PubMed ID: 11879619 [Abstract] [Full Text] [Related]
4. [Epidermal growth factor receptor in non-small cell cancer of the lung]. Díez M, Maestro ML, Torres A, Hernando F, Ortega MD, García-Asenjo JA, Picardo A, Mugüerza JM, Sánchez-Pernaute A, Balibrea JL. Arch Bronconeumol; 1994 Apr; 30(6):282-6. PubMed ID: 8087386 [Abstract] [Full Text] [Related]
5. Prognostic significance of overexpressed matrix metalloproteinase-2, mouse-double minute: 2 homolog and epidermal growth factor receptor in non-small cell lung cancer. Jiang LY, Bi R, Ding FB, Wang MS, Mei J, He Y. J BUON; 2016 Apr; 21(2):341-8. PubMed ID: 27273943 [Abstract] [Full Text] [Related]
6. Epidermal growth factor receptor in lung malignancies. Comparison between cancer and normal tissue. Dittadi R, Gion M, Pagan V, Brazzale A, Del Maschio O, Bargossi A, Busetto A, Bruscagnin G. Br J Cancer; 1991 Oct; 64(4):741-4. PubMed ID: 1654986 [Abstract] [Full Text] [Related]
8. [Thyroid transcription factor-1 level is associated with epidermal growth factor receptor mutation status in patients with advanced lung adenocarcinoma]. Niu Y, Wang H, Zhang G, Ma J, Wei B, Ma Z. Zhonghua Jie He He Hu Xi Za Zhi; 2014 Dec; 37(12):919-23. PubMed ID: 25609130 [Abstract] [Full Text] [Related]